Selective inhibition of NF-κB-inducing kinase (NIK) leads to improved survival of SLE mice in vivo. NIK mediates the activation of TNF proteins that have been implicated in SLE pathogenesis (15). Here, TNF is linked to systemic lupus erythematosus.